Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bladder cancer: realities and perspectives].

Yves Chrétien1, Stéphane Oudard, Catherine Durdux

  • 1Radiothérapie, Hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris.

Bulletin Du Cancer
|March 1, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GABA promotes resistance to immunotherapy in patients with TLS-positive tumors.

Cancer cell·2026
Same author

Cyclin E1 overexpression identifies a therapeutically relevant poor prognostic patient subgroup in high-grade serous ovarian cancer.

NPJ precision oncology·2026
Same author

Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 Trials.

European urology oncology·2026
Same author

Cabozantinib in patients with non-locally pretreated brain metastases from renal cell carcinoma: Results of the multicenter phase II trial CABRAMET.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Radionecrosis risk and local control after CyberKnife<sup>®</sup> fractionated stereotactic radiotherapy for brain metastases: an eight-year single-centre cohort.

Radiation oncology (London, England)·2026

Bladder cancer treatment involves surgery, chemotherapy, and radiation, with new drugs improving outcomes for metastatic disease. Advances offer better quality of life and functional bladder preservation for patients.

Area of Science:

  • Uro-oncology
  • Cancer research
  • Medical treatment

Context:

  • Bladder cancer is a common urologic malignancy.
  • Treatment necessitates a multidisciplinary team approach.
  • Superficial tumors managed with instillations or cystectomy; invasive tumors require radical cystectomy.

Purpose:

  • To outline current treatment strategies for bladder cancer.
  • To discuss surgical options including ileal reconstructions.
  • To review alternative treatments like chemoradiotherapy and emerging therapies for metastatic disease.

Summary:

  • Radical cystectomy is standard for invasive bladder cancer, with ileal reconstructions enhancing quality of life.
  • Chemoradiotherapy offers a viable alternative to radical cystectomy in selected patients, achieving 50-60% bladder preservation.

Related Experiment Videos

  • Metastasis affects nearly half of patients, highlighting the need for novel systemic therapies.

    • Impact:

    • Improved patient outcomes through tailored treatment strategies.
    • Enhanced quality of life via reconstructive surgery options.
    • Advancements in managing metastatic bladder cancer with new chemotherapeutic agents.